Author Affiliations: Departments of Dermatology (Drs Jiménez-Gallo, Albarrán-Planelles, Linares-Barrios, and Martínez-Rodríguez) and Pathology (Dr Báez-Perea), Puerta del Mar University Hospital, Cadiz, Spain.
The onset of eruptive melanocytic nevi (EMN) is an uncommon phenomenon characterized by sudden onset of multiple melanocytic nevi (MN). This phenomenon has been linked primarily to bullous diseases or conditions of immunosuppression. A newly described cause of EMN is the multikinase inhibitor sorafenib and its relationship to inhibition of the BRAFV600E mutation (Table).1,2
Jiménez-Gallo D, Albarrán-Planelles C, Linares-Barrios M, Martínez-Rodríguez A, Báez-Perea JM. Eruptive Melanocytic Nevi in a Patient Undergoing Treatment With Sunitinib. JAMA Dermatol. 2013;149(5):624-626. doi:10.1001/jamadermatol.2013.263